Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203911 · ClinicalTrials.gov registry record · NA
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
A NA study of Oral Cancer and Tongue Cancer, sponsored by Tobias Todsen.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 7
- Study locations
NCT07203911: Recruiting NA study of Oral Cancer and Tongue Cancer, sponsored by Tobias Todsen.
NCT07203911 is a NA study of Oral Cancer and Tongue Cancer that is actively recruiting participants, run by Tobias Todsen. The registered enrollment target is 200 participants, roughly in line with the 201-participant average among 17 other Oral Cancer trials with a reported enrollment target. The trial reports 7 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203911, a NA study of Oral Cancer and Tongue Cancer, is actively recruiting participants, sponsored by Tobias Todsen.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 7
- Study locations
Study Summary
The goal of this clinical trial is to improve the surgical treatment of patients with oral cancer. We will explore whether the use of surgeon performed ultrasound during these surgeries result in better tumor removal. We hypothesize that using intraoperative ultrasound to assist the resection results in more frequent clear surgical margins in oral cancer surgeries compared to standard methods. This improvement is associated with a reduced need for post-operative adjuvant therapies such as radiotherapy and reoperation, lower mortality rates, lower cancer recurrence, and enhanced quality of life for patients undergoing surgery for oral cancer. Participants will be randomized to either the control or intervention group: * Control group will receive standard treatment for oral cancer. * Intervention group will in addition to the standard treatment have surgery performed using ultrasound to guide the resection and evaluate resection margins intraoperatively. Outcomes: * Number of free surgical margins between control and intervention group. * Intraoperative surgeon assessed surgical margins compared to final histology report. * Dysphagia and quality of life questionnaires. * Recurrence rates. * Mortality rates. All participant will be followed-up at 3 months and 12 months with: * MDADI dysphagia questionnaire * EORTC head and neck cancer quality of life questionnaire * Follow-up on recurrrence and mortality.
Primary Outcome
Surgeons prediction of deep margin in mm
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound imaging
- OTHER Standard Treatment
Study Locations (7)
Other
- Department of Otorhinolaryngology Head and Neck Surgery - Aarhus
- Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet - Copenhagen
- Istituto Nazionale Tumori of Milan - Milan
- Groote Schuur - Cape Town
- Karolinska Institute - Stockholm
California
- Stanford Otolaryngology - Head & Neck Surgery Department - Stanford
Georgia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2031-08 |
| Phase | NA |
What NCT07203911 shows while recruiting
NCT07203911 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 201-participant average among 17 other Oral Cancer trials with a reported enrollment target.
The record links to 3 conditions, with Oral Cancer appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound imaging is the first listed.
NCT07203911 lists 7 locations in 3 states (Other, California, Georgia).
Frequently Asked Questions
What is clinical trial NCT07203911 about?
NCT07203911 is a clinical study titled "Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial". The goal of this clinical trial is to improve the surgical treatment of patients with oral cancer. We will explore whether the use of surgeon performed ultrasound during these surgeries result in better tumor removal. We hypothesize that using intraoperative ultrasound to assist the resection result...
What is the current status of trial NCT07203911?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-09-15. Estimated completion is 2031-08.
What conditions does trial NCT07203911 study?
This clinical trial studies the following conditions: Oral Cancer, Tongue Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx.
What interventions are being tested in trial NCT07203911?
The interventions under investigation include: Ultrasound imaging (DIAGNOSTIC_TEST), Standard Treatment (OTHER).
Who is sponsoring clinical trial NCT07203911?
This trial is sponsored by Tobias Todsen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07203911 being conducted?
This trial has 7 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oral Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07203911's enrollment target sits among peer trials
200 4th of 17 higher than 14 of 17 other Oral Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oral Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
RECRUITING · NA
-
Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
RECRUITING · NA
-
Enhancing Oral Cancer Awareness
RECRUITING · NA
-
Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
ACTIVE NOT RECRUITING · NA
-
Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI